1.      Whiting D, Leonor G, Clara W, Jonathan S . Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research Hand Clinical Practice  2011;94(3): 311-321

2.      Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG,et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N EnglJMed 2001;345:790-97

3.      Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care  2003;26:645-49

4.      Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J ClinNutr  2006;84:18-28

5.      Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo ClinProc 2006;81:353-73

6.      Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends EndocrinolMetab 2005;16:261-66

7.      Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92(6):2017-29

8.      Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr 2004;79(5):820-5

9.      DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J ClinNutr  2004;80(6):1689S-96S

10.  Bikle D. Nonclassic actions of vitamin D. J ClinEndocrinolMetab  2009;94(1):26-34

11.  Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet  2001;358 (9292):1500-3

12.  Ortlepp JR, Metrikat J, Albrecht M, Von Korff A, Hanrath P, Hoffmann R. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in health young men. Diabet Med 2003;20(5):451-4

13.  Binkly N, Krueger D, Cowgill CS, Plum L, Lake E,Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D:a call for standardi-zation. J Clin Endocrinol Metab  2004;89(7):315-7

14.  Zargar AH, Ahmad S, Masoodi SR, Wani AI, Bashir MI, Laway BA, et al. Vitamin D status in apparently healthy adults in Kashmir valley of Indian subcontinent. Postgrad Med J  2007;83(985):713-6

15.  Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J ClinNutr  2005;82(2):477-82

16.  Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J ClinNutr 2004; 79: 362-71

17.  Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-85  

18.  Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003; 88: 216–22   

19.  Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, Abraham A, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. ActaDiabetol 2009;46(3):183-9

20.  Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus.JPediatr 2009;154(1):132-4

21.  Littorin B, Blom P, Schölin A, Arnqvist HJ, Blohmé G, Bolinder J, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia  2006;49 (12):2847-52

22.  Isaia G , Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496

23.  Targher G , Bertolini L , Padovani R, Zenari L, Scala L, CigoliniM,Arcaro G . Serum 25-hydroxyvitamin D3 concentrat-ions and carotid artery intima-media thickness among type 2 diabetic patients. ClinEndocrinol (Oxf) 2006;65:593-7     

24.  Deleskog A, Hilding,  Brismar K, Hamsten A ,Efendic S , Ostenson CG . Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 2012;55:1668-78         

25.  Forouhi NG,  Luan J, Cooper A,Boucher BJ, Wareham NJ . Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-25                   

26.  Gagnon C,  Lu ZX,  Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011;34:1133-8

27.  Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with beta-cell function and glycemia: the PRO spective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 2011;60:2947–53      

28.  Janner M, Ballinari P, Mullis PE, Flück CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly  2010;140:w13091

29.  Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, et al. IMDIAB group. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diab-etes. Horm Metab Res 2005;37 (11):680-3

30.  Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature  2001;414(6865):782-7

31.  Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Third National Health and Nutrition Examination Survey. Diabetes Care  2004;27(12):2813-8

32.  Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunc-tion. Am J ClinNutr 2004;79 (5):820-5

33.  Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. DiabetMed  2007;24 (2):200-7

34.  Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, et al.       Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012;35:565-73

35.  Mattila C,  Knekt P,  Mannisto S,  Rissanen H, Laaksonen MA, Montonen J, et al.  Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569-70                                                                  

36.  Grimnes G,  Emaus N,  Joakimsen RM, Figenschau Y, Jenssen T, Njolstad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010;27:1107-15.